Clinical trial

Feasibility Study for Development of an Early Test for Ovarian Failure

NCT00006156 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed

Key facts

NCT number NCT00006156
Title Feasibility Study for Development of an Early Test for Ovarian Failure
Official title FSH-Stimulated Inhibin B as a Marker for Early Ovarian Insufficiency
Lead sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH
Collaborators National Institutes of Health Clinical Center (CC) NIH
Status Completed
Study type Interventional
Conditions Healthy, Premature Ovarian Failure
Intervention type Drug, Other
Interventions Control, Drug: FSH
Enrollment 49
Start date Aug 1, 2000
Primary completion Jan 1, 2012
Completion Jan 1, 2012
First posted Aug 10, 2000
Last update posted May 16, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies